188
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Pediatric Ocular Toxocariasis in Costa Rica: 1998-2018 Experience

, MDORCID Icon, , MDORCID Icon & , MDORCID Icon
Pages 1246-1251 | Received 17 May 2020, Accepted 02 Jul 2020, Published online: 18 Aug 2020

References

  • Lee RM, Moore LB, Bottazzi ME, Hotez PJ. Toxocariasis in North America: a systematic review. PLoS Negl Trop Dis. 2014: 8(8):e3116. Public Library of Science
  • Martínez-Pulgarín DF, Muñoz-Urbano M, Gomez-Suta LD, Delgado OM, Rodríguez-Morales AJ. Ocular toxocariasis: new diagnostic and therapeutic perspectives. Recent Pat Antiinfect Drug Discov. 2015;10:35–41.
  • Chen J, Liu Q, Liu G-H, et al. Toxocariasis: a silent threat with a progressive public health impact. Infect Dis Poverty. 2018;7:1–13.
  • Lötsch F, Vingerling R, Spijker R, Grobusch MP. Toxocariasis in humans in Africa – A systematic review. Travel Med Infect Dis. 2017;12:1–41.
  • Sampasa-Kanyinga H, Lévesque B, Anassour-Laouan-Sidi E, et al. Zoonotic infections in communities of the James Bay Cree territory: an overview of seroprevalence. Can J Infect Dis Med Microbiol. 2013;24(2):79–84.
  • Stensvold CR, Skov J, Møller LN. et al., Seroprevalence of human toxocariasis in Denmark. Clin Vaccine Immunol. 2009;16(9):1372–1373. American Society for Microbiology
  • Fan C-K, Hung -C-C, Du W-Y, Liao C-W, Su K-E. Seroepidemiology of Toxocara canis infection among mountain aboriginal schoolchildren living in contaminated districts in eastern Taiwan. Trop Med Int Health. 2004;9:1312–1318.
  • Bolivar-Mejia A, Alarcón-Olave C, Calvo-Betancourt LS, et al. Toxocariasis in the Americas: burden and disease control. Curr Trop Med Rep. 2014;1:62–68
  • Ahn SJ, Ryoo N-K, Woo SJ. Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention. Asia Pac Allergy. 2014;4:134–141.
  • Arevalo JF, Espinoza JV, Arevalo FA. Ocular Toxocariasis. J Pediatr Ophthalmol Strabismus. Aug 28, 2012;50(2):76–86.
  • Stewart JM, Cubillan LD, Cunningham ET Jr. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina. 2005;25:1005–1013.
  • Lötsch F, Obermüller M, Mischlinger J, et al. Seroprevalence of Toxocara spp. in a rural population in Central African Gabon. Parasitol Int. 2016;7:1–3.
  • Paquet-Durand I, Hernández J, Dolz G, Zuñiga JJR, Schnieder T, Epe C. Prevalence of Toxocara spp., Toxascaris leonina and ancylostomidae in public parks and beaches in different climate zones of Costa Rica. Acta Trop. 2007;104:30–37.
  • Yoshida M, Shirao Y, Asai H, et al. A retrospective study of ocular toxocariasis in Japan: correlation with antibody prevalence and ophthalmological findings of patients with uveitis. J Helminthol. 1999;73(4):357–361.
  • Ahn SJ, Woo SJ, Jin Y, et al. Clinical features and course of Ocular Toxocariasis in adults. PLoS Negl Trop Dis. 2014 12;8(6):e2938–12.
  • Despreaux R, Fardeau C, Touhami S, et al. Ocular Toxocariasis: clinical features and long-term visual outcomes in adult patients. Am J Ophthalmol. 2016;7:1–15.
  • Wilkinson CP, Welch RB. Intraocular toxocara. Am J Ophthalmol. 1971;71:921–930.
  • Woodhall D, Starr MC, Montgomery SP, et al. Ocular toxocariasis: epidemiologic, anatomic, and therapeutic variations based on a survey of ophthalmic subspecialists. Ophthalmology. 2012;119(6):1211–1217.
  • Magnaval JF. Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis. Parasitology. 1995;110:529–533.
  • Sturchler D, Schubarth P, Gualzata M, Gottstein B, Oettli A. Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. Ann Trop Med Parasitol. 1989;83:473–478.
  • Dinning WJ, Gillespie SH, Cooling RJ, Maizels RM. Toxocariasis: a practical approach to management of ocular disease. Eye (Lond). 1988;2:580–582.
  • Maguire AM, Zarbin MA, Connor TB, Justin J. Ocular penetration of thiabendazole. Arch Ophthalmol. 1990;108:1675.
  • Amin HI, McDonald HR, Han DP, et al. Vitrectomy update for macular traction in ocular toxocariasis. Retina. 2000;20:80–85.
  • Zhang T, Guo D, Xu G, Jiang R. Ocular Toxocariasis: long-term follow-up and prognosis of patients following vitrectomy. Ocul Immunol Inflamm. 2020;28(3):517–5232019;1–7.
  • Small KW, McCuen BW 2nd, de Juan E Jr., Machemer R. Surgical management of retinal traction caused by toxocariasis. Am J Ophthalmol. 1989;108:10–14.
  • Rodriguez A. Early pars plana vitrectomy in chronic endophthalmitis of toxocariasis. Graefes Arch Clin Exp Ophthalmol. 1986;224:218–220.
  • Werner JC, Ross RD, Green WR, Watts JC. Pars plana vitrectomy and subretinal surgery for ocular toxocariasis. Arch Ophthalmol. 1999;117:532–534.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.